(Q36901654)

17 August 2017

1 reference

title

Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma (English)

1 reference

17 August 2017

1 reference

Azizul Haque

1

1 reference

PubMed ID

17676389

17 August 2017

Naren L Banik

series ordinal

2

1 reference

PubMed ID

17676389

17 August 2017

Swapan K Ray

series ordinal

3

1 reference

17 August 2017

4 August 2007

1 reference

17 August 2017

Neurochemical Research

1 reference

17 August 2017

32

1 reference

17 August 2017

12

1 reference

17 August 2017

2203-2209

1 reference

https://scigraph.springernature.com/pub.10.1007/s11064-007-9420-z

17 August 2017

0 references

cites work

Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but CIITA-independent

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11064-007-9420-Z

Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11064-007-9420-Z

Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11064-007-9420-Z

Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes

21 January 2018

1 reference

12 December 2020

Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.

1 reference

12 December 2020

Physiological and receptor-selective retinoids modulate interferon gamma signaling by increasing the expression, nuclear localization, and functional activity of interferon regulatory factor-1.

1 reference

12 December 2020

Mechanisms of malignant glioma immune resistance and sources of immunosuppression

1 reference

12 December 2020

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

1 reference

12 December 2020

Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia

1 reference

12 December 2020

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

12 December 2020

Targeting malignant glioma survival signalling to improve clinical outcomes.

1 reference

12 December 2020

EphA2 as a glioma-associated antigen: a novel target for glioma vaccines

1 reference

12 December 2020

Treatment of unresectable glioblastoma multiforme.

1 reference

12 December 2020

Surgical management of high-grade gliomas

1 reference

12 December 2020

Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival

1 reference

12 December 2020

Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes

1 reference

12 December 2020

Effect of all-trans-retinoic acid on cytokine production in a murine macrophage cell line

1 reference

12 December 2020

Tumor-specific CD4+ T cells from a patient with renal cell carcinoma recognize diverse shared antigens

1 reference

12 December 2020

Radioimmunotherapy of brain tumor.

1 reference

12 December 2020

Retinoic acid-induced apoptotic pathway in T-cell lymphoma: Identification of four groups of genes with differential biological functions

1 reference

12 December 2020

Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells

1 reference

12 December 2020

Glioma stem cells: evidence and limitation

1 reference

12 December 2020

HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells

1 reference

12 December 2020

Activation of tumor-specific CD4(+) T lymphocytes by major histocompatibility complex class II tumor cell vaccines: a novel cell-based immunotherapy.

1 reference

12 December 2020

Effect of all-trans-retinoic acid on the differentiation, maturation and functions of dendritic cells derived from cord blood monocytes

1 reference

12 December 2020

Recent advances in immunotherapy for human glioma

1 reference

12 December 2020

Gliomas: advances in molecular analysis and characterization

1 reference

12 December 2020

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

1 reference

12 December 2020

Predictive and prognostic markers in human glioblastomas

1 reference

12 December 2020

CD117 expression in glial tumors

1 reference

12 December 2020

Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain

1 reference

12 December 2020

YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.

1 reference

12 December 2020

All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.

1 reference

12 December 2020

Cytokines and Immune Response in the Tumor Microenvironment.

1 reference

12 December 2020

Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).

1 reference

12 December 2020

Processing and presentation of tumor antigens and vaccination strategies

1 reference

12 December 2020

Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes.

1 reference

12 December 2020

Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.

1 reference

12 December 2020

Regulation of intercellular adhesion molecule-1 expression by retinoic acid: analysis of the 5' regulatory region of the gene

1 reference

12 December 2020

Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells

1 reference

12 December 2020

Transcription of retinoic acid receptor genes in transgenic mice increases CD8 T-cell subset

1 reference

12 December 2020

Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression

1 reference

12 December 2020

New insights in antigen processing and epitope selection: development of novel immunotherapeutic strategies for cancer, autoimmunity and infectious diseases.

1 reference

12 December 2020

Differential MHC class II component expression in HPV-positive cervical cancer cells: implication for immune surveillance

1 reference

12 December 2020

Anomalous expression of the HLA-DR alpha and beta chains in ovarian and other cancers

1 reference

12 December 2020

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

1 reference

12 December 2020

A novel glioblastoma cancer gene therapy using AAV-mediated long-term expression of human TERT C-terminal polypeptide.

1 reference

12 December 2020

Therapeutic options for recurrent high-grade glioma in adult patients: recent advances

1 reference

12 December 2020

Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme

1 reference

12 December 2020

Therapeutic advances for glioblastoma multiforme: current status and future prospects.

1 reference

12 December 2020

10.1007/S11064-007-9420-Z

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17676389